Innovita Biological Technology Co., Ltd. (SHA:688253)
China
· Delayed Price · Currency is CNY 32.54
+1.68 (5.44%)
At close: May 8, 2025, 2:57 PM CST
SHA:688253 Revenue
Innovita Biological Technology had revenue of 206.97M CNY in the quarter ending March 31, 2025, a decrease of -26.51%. This brings the company's revenue in the last twelve months to 546.74M, down -12.54% year-over-year. In the year 2024, Innovita Biological Technology had annual revenue of 621.39M with 29.99% growth.
Revenue (ttm)
546.74M
Revenue Growth
-12.54%
P/S Ratio
8.03
Revenue / Employee
999.53K
Employees
404
Market Cap
4.39B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |